Fredrik Lindblad
BiBBInstruments CEO: "First order sends positive signals"
BiBB CEO: "Zagreb confirms fine samples and short learning curve"
The clinical introduction is in full swing for...
EndoDrill is seen as promising new EUS technology
During the ESGE days in Berlin, BiBBInstruments' endoscopic ultrasound instrument was named...
BiBB ready for the European market
Cancer diagnostics company BiBBInstruments has received market approval in the EU and
BiBBInstruments' premiere of EndoDrill was received with enthusiasm
While waiting for a long-awaited CE certificate according to MDR...
BiBBInstruments CEO: "Exciting times await"
So far this year, BiBBInstruments has secured FDA market approval...
BiBBInstruments about the private placement
After receiving FDA approval for...
BiBBInstruments on FDA approval and price reaction
Last week, medical technology company BiBBInstruments received good news from...
BiBBInstruments wants to revolutionize the diagnostics of pancreatic cancer
Currently, pancreatic cancer is detected far too often in...
BiBBInstruments faces an eventful 2023
For medtech company BiBBInstruments, 2022 was a year of...
BiBBInstruments about the upcoming patent approval
Swedish medical technology company BiBBInstruments is developing the world's first CE-marked...
BiBBInstruments comments on the Q3 report
This year's Q3 report makes it clear that the cancer diagnostics company...